Pharmacodynamic effects of subinhibitory antibiotic concentrations.
about
When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transitionTigecycline: first of a new class of antimicrobial agentsPreclinical evaluation of novel antibacterial agents by microbiological and molecular techniquesPharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients.Method for measuring postantifungal effect in Aspergillus species.Biofilm formation on biotic and abiotic surfaces in the presence of antimicrobials by Escherichia coli Isolates from cases of bovine mastitisLow levels of β-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureusRate of elimination of Wolbachia pipientis by doxycycline in vitro increases following drug withdrawal7-O-malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepaciaPredicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model.Effects of intracanal irrigant MTAD Combined with nisin at sub-minimum inhibitory concentration levels on Enterococcus faecalis growth and the expression of pathogenic genes.Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms.Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials.Pharmacological considerations for the proper clinical use of aminoglycosides.Induction of MRSA Biofilm by Low-Dose β-Lactam Antibiotics: Specificity, Prevalence and Dose-Response Effects.Postantibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA.Antibacterial Activity of 7-Epiclusianone and Its Novel Copper Metal Complex on Streptococcus spp. Isolated from Bovine Mastitis and Their Cytotoxicity in MAC-T Cells.Post-antibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs.Influence of sub-inhibitory antibiotics and flow condition on Staphylococcus aureus ATCC 6538 biofilm development and biofilm growth rate: BioTimer assay as a study model.Postantibiotic effects of daptomycin against 14 staphylococcal and pneumococcal clinical isolates.Postantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickens.Concerns about 99mTc-labelled ciprofloxacin for infection detection.Effects of subminimal inhibitory concentrations of amoxicillin against Actinobacillus pleuropneumoniae.Exposure time-dependent bactericidal activities of amoxicillin against Actinobacillus pleuropneumoniae; an in vitro and In vivo pharmacodynamic model.Effects of antibiotics on Pseudomonas aeruginosa NK125502 and Pseudomonas fluorescens MF0 biofilm formation on immobilized fibronectin.Bergenin Plays an Anti-Inflammatory Role via the Modulation of MAPK and NF-κB Signaling Pathways in a Mouse Model of LPS-Induced Mastitis.Antibiotic Persistence as a Metabolic Adaptation: Stress, Metabolism, the Host, and New Directions.Combined Antimicrobial Activity of Photodynamic Inactivation and Antimicrobials-State of the Art.
P2860
Q21145725-0C8305AC-799C-4DFA-AD43-FE99F052D60BQ28253736-023CEAC4-9F16-4A36-B873-F859CB3360D7Q28273315-C8F74FDA-7CAD-4308-862D-4B07DFCB90BCQ33802909-14CEE5DB-3253-4EC0-8C4F-E179D74619C7Q34108018-EFE2915A-0719-4848-9E13-C0459C4873FDQ34261410-CB89987C-546A-4286-A0D6-6550B7F218BFQ34291700-59E1746A-6CB2-432D-9C07-0D82F59EAFABQ34509785-8E562A05-2310-4BCF-8B80-E8EA0D399BC2Q34648847-3959C020-7540-4AE9-84B9-E92B802CE376Q34737629-E48258C6-7D79-434B-B211-3856AC82C752Q35113099-DBB50942-7B6D-4D85-AEAC-6A2A05D2E7ECQ35901841-A8E96AF2-2D77-4250-B805-B63337AEF286Q36320595-FC485B24-9A9D-4CF6-B857-BF7184502ADAQ37956403-2BBEA33A-B7DB-453A-A27A-02500FB5BDE1Q38370309-3339393C-6D07-4BA9-8121-43C288DEF176Q39671220-C3763F47-8DE5-4080-B59E-AA62EFE37AF6Q40209447-99A9026E-93DA-499B-948A-424204ABFC6CQ42007756-60A50368-2185-486E-8F14-05F01219215CQ42213557-333DDAA8-8D27-41F8-AAC8-703155A04BECQ42925097-734703E7-3EF0-4B63-A5A6-6F5E12D51B11Q43467221-ACB06A81-5BA7-4372-9A8F-F124DEB61963Q43663744-4068E3CE-6631-449C-8A3F-A268EE96528DQ44251235-64FF88ED-2E33-48C6-8A74-BFBD4095D7F8Q44665771-9DBA21AE-710C-4C95-A471-C2440AA51A6CQ45031117-34BB3164-03F0-4187-9E57-F68B660D0523Q46801082-6AFA9644-1D17-4FFE-B745-131809600285Q48124256-D5F5D947-7A2A-412B-8A43-11B0E966D92DQ55006895-0AF462AB-69D7-4DDB-945D-21C596BA88C4
P2860
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
@ast
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
@en
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
@nl
type
label
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
@ast
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
@en
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
@nl
prefLabel
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
@ast
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
@en
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
@nl
P1476
Pharmacodynamic effects of subinhibitory antibiotic concentrations.
@en
P2093
Odenholt I
P356
10.1016/S0924-8579(00)00243-0
P577
2001-01-01T00:00:00Z